Trial Profile

Basal Insulin in the Management of Patients With Diabetic Ketoacidosis.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 01 Nov 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin glargine (Primary) ; Insulin glulisine (Primary) ; Insulin; Insulin suspension isophane
Indications Diabetes mellitus; Diabetic ketoacidosis
Focus Therapeutic Use

Most Recent Events

11 Dec 2009 Actual number of patients changed from 60 to 74 as reported by ClinicalTrials.gov.
07 Sep 2008 Results presented at the 44th Annual Meeting of the European Association for the Study of Diabetes
19 Aug 2008 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com